News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY) Reports Second Quarter 2014 Financial Results And A Clinical/Business Update


7/31/2014 10:46:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infectives, today reported second quarter 2014 financial results and provided a clinical and commercialization update.

“In July, we announced a major marketing and commercialization campaign for the company’s new product, i-LidTMCleanser. The effort is led by Glenn Moro, our new Vice President of Sales and Marketing, who has a long and successful track record of launching products in this ophthalmology and optometry space,” commented Ron Najafi, Ph.D., Chairman and CEO of NovaBay Pharmaceuticals.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES